Fig. 3. The landscape of genes and cancer types in DFCI precision medicine trials.
a, b Number of trials in MatchMiner for select genomic criteria (≥10 trials) and number of trials that have 1, 2, 3, 4, and ≥ 5 genomic criteria. c, d Number of trials in MatchMiner for select cancer types (>4 trials) and number of trials that have 1, 2, 3, and ≥ 4 specific cancer types. NSCLC non-small cell lung cancer, GIST gastrointestinal stromal tumor. MNT Miscellaneous Neuroepithelial Tumor. Trials with eligibility for all solid or all liquid tumors were not included in (d).